Report Scope:
This research report categorizes the antiulcerant drugs market by type, including proton pump inhibitors, H2 receptor antagonists, gastric mucosal protective drugs, antibiotics, antacids and prostaglandin agonists.
Report Includes:
- 97 data tables
- Country specific data and analysis for China, India, Japan, Australia, UK, Germany, France, Italy, Spain, Russia, USA and Brazil
- Insight into technological advances, such as big data, 3D printing and IoT in the growth of the antiulcerants drugs market
- Coverage of definition, types, causes, and treatment options for ulcers
- Description of the modes of action of various antiulcer drugs
- Comprehensive profiles of major players in the market, including AstraZeneca, Allergan, Daewoong Pharmaceutical, Eisai, and Takeda Pharmaceutical
Table of Contents
1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Currencies
- Geographic Breakdown
- Analyst's Credentials
- Related Reports
3 Antiulcerant Drugs Market Overview
- Antiulcerant Drugs Market characteristics
- Types of Ulcers
- Stomach Ulcers
- Leg Ulcer
- Peptic Ulcers
- Esophageal Ulcer
- Bleeding Ulcer
- Refractory Ulcer
- Stress Ulcer
- Mouth Ulcers
- Venous Stasis Ulcers
- Neuropathic Ulcers
- Arterial (Ischemic) Ulcers
- Pressure Ulcers
- Causes of Ulcers
- Drug Types and Mode of Action
- Proton Pump Inhibitors
- H2 Receptor Antagonists
- Gastric Mucosal Protective Drugs
- Antibiotics
- Antacids
- Prostaglandin Agonists
- Antiulcerant Drugs Market Size and Growth
- Historic Market Growth
- Forecast Market Growth
- Antiulcerant Drugs Market Trends and Strategies
- Growing Popularity of E-Commerce Platforms
- Technological Advances in Ulcer Drugs
- 3D Printing Technology
- Tranexamic Acid to Treat Gastrointestinal Bleeding
4 PESTEL Analysis
- Political
- Economic
- Social
- Technological
- Environmental
- Legal
5 Global Antiulcerant Drugs Market Comparison with Macro Economic Factors
- Global Per Capita Average Antiulcerant Drugs Market Expenditure
- Per Capita Average Antiulcerant Drugs Market Expenditure, By Country
- Global Antiulcerant Drugs Market Size, Percentage of GDP
- Global Antiulcerant Drugs Market Size, Percentage Of GDP, By Country
6 Antiulcerant Drugs Market Segmentation
- Global Antiulcerant Drugs Market, by Segment
- Global Antiulcerant Drugs Market, Historic and Forecast, by Segment, 2013-2022
7 Antiulcerant Drugs Market Regional and Country Analysis
- Global Antiulcerant Drugs Market, by Region, 2017
- Global Antiulcerant Drugs Market, Historic and Forecast, by Region, 2013-2022
- Global Antiulcerant Drugs Market Segmentation, by Region, 2017
- Global Antiulcerant Drugs Market, by Country, 2017
- Global Antiulcerant Drugs Market, Historic and Forecast, by Country, 2013-2022
- Global Antiulcerant Drugs Market Segmentation, by Country, 2017
8 Asia-Pacific Antiulcerant Drugs Market
- Asia-Pacific Antiulcerant Drugs Market Overview
- Region Information
- Market Information
- Background Information
- End User Industries Information
- Government Initiatives
- Investments
- Regulations
- Regulatory Bodies
- Taxes Levied
- Corporate Tax Structure
- Major Associations
- Major Companies
- Asia-Pacific Antiulcerant Drugs Historic Market, 2013-2017
- Asia-Pacific Antiulcerant Drugs Forecast Market, 2017-2022
- Asia-Pacific Antiulcerant Drugs Market Size, by Segment, 2017
- Asia-Pacific Antiulcerant Drugs Market, Historic and Forecast, by Segment, 2013-2022
- Asia-Pacific Antiulcerant Drugs Market: Country Analysis
- China Antiulcerant Drugs Market Overview
- India Antiulcerant Drugs Market Overview
- Japan Antiulcerant Drugs Market Overview
- Australia Antiulcerant Drugs Market
9 Western Europe Antiulcerant Drugs Market
- Western European Antiulcerant Drugs Market Overview
- Region Information
- Market Information
- End User Customer Information
- Background Information
- Government Initiatives
- Investments
- Regulations
- Regulatory Bodies
- Taxes Levied
- Corporate Tax Structure
- Major Associations
- Major Companies
- Western Europe Antiulcerant Drugs Historic Market, 2013-2017
- Western Europe Antiulcerant Drugs Forecast Market, 2017-2022
- Western Europe Antiulcerant Drugs Market Size, by Segment, 2017
- Western Europe Antiulcerant Drugs Market, Historic and Forecast, by Segment, 2013-2022
- Western Europe Antiulcerant Drugs Market: Country Analysis
- United Kingdom Antiulcerant Drugs Market Overview
- Germany Antiulcerant Drugs Market
- France Antiulcerant Drugs Market
- Italy Antiulcerant Drugs Market
- Spain Antiulcerant Drugs Market
10 Eastern Europe Antiulcerant Drugs Market
- Eastern European Antiulcerant Drugs Market Overview
- Region Information
- Market Information
- Background Information
- End User Industries Information
- Government Initiatives
- Investments
- Regulations
- Regulatory Bodies
- Taxes Levied
- Corporate Tax Structure
- Major Associations
- Major Companies
- Eastern Europe Antiulcerant Drugs Historic Market, 2013-2017
- Eastern Europe Antiulcerant Drugs Forecast Market, 2017-2022
- Eastern Europe Antiulcerant Drugs Market Size, by Segment, 2017
- Eastern Europe Antiulcerant Drugs Market, Historic and Forecast, by Segment, 2013-2022
- Eastern Europe Antiulcerant Drugs Market: Country Analysis
- Russia Antiulcerant Drugs Historic Market, 2013-2017
- Russia Antiulcerant Drugs Forecast Market, 2017-2022
- Russia Antiulcerant Drugs Market Size, by Segment, 2017
- Russia Antiulcerant Drugs Market, Historic and Forecast, by Segment, 2013-2022
11 North America Antiulcerant Drugs Market
- North America Antiulcerant Drugs Market Overview
- Region Information
- Market Information
- Background Information
- End User Industries Information
- Investments
- Regulations
- Regulatory Bodies
- Taxes Levied
- Corporate Tax Structure
- Major Associations
- Major Companies
- North America Antiulcerant Drugs Historic Market, 2013-2017
- North America Antiulcerant Drugs Forecast Market, 2017-2022
- North America Antiulcerant Drugs Market Size, by Segment, 2017
- North America Antiulcerant Drugs Market, Historic and Forecast, by Segment, 2013-2022
- North America Antiulcerant Drugs Market: Country Analysis
- USA Antiulcerant Drugs Market
- USA Antiulcerant Drugs Forecast Market, 2017-2022
- USA Antiulcerant Drugs Market Size, by Segment, 2017
- USA Antiulcerant Drugs Market, Historic and Forecast, by Segment, 2013-2022
12 South America Antiulcerant Drugs Market
- South America Antiulcerant Drugs Market Overview
- Region Information
- Market Information
- End User Customer Information
- Background Information
- Government Initiatives
- Regulations
- Regulatory Bodies
- Major Associations
- Taxes Levied
- Corporate Tax Structure
- Major Companies
- South America Antiulcerant Drugs Historic Market, 2013-2017
- South America Antiulcerant Drugs Forecast Market, 2017-2022
- South America Antiulcerant Drugs Market Size, by Segment, 2017
- South America Antiulcerant Drugs Market, Historic and Forecast, by Segment, 2013-2022
- South America Antiulcerant Drugs Market: Country Analysis
- Brazil Antiulcerant Drugs Market
13 Middle East Antiulcerant Drugs Market
- Middle East Antiulcerant Drugs Market Overview
- Region Information
- Market Information
- End User Customer Information
- Background Information
- Government Initiatives
- Investments
- Regulations
- Regulatory Bodies
- Taxes Levied
- Corporate Tax Structure
- Major Associations
- Major Companies
- Middle East Antiulcerant Drugs Historic Market, 2013-2017
- Middle East Antiulcerant Drugs Forecast Market, 2017-2022
- Middle East Antiulcerant Drugs Market Size, by Segment, 2017
- Middle East Antiulcerant Drugs Market, Historic and Forecast, by Segment, 2013-2022
14 Africa Antiulcerant Drugs Market
- Africa Antiulcerant Drugs Market Overview
- Region Information
- Market Information
- End User Customer Information
- Background Information
- Government Initiatives
- Investments
- Regulations
- Regulatory Bodies
- Taxes Levied
- Corporate Tax Structure
- Major Associations
- Major Companies
- Africa Antiulcerant Drugs Historic Market, 2013-2017
- Africa Antiulcerant Drugs Forecast Market, 2017-2022
- Africa Antiulcerant Drugs Market Size, by Segment, 2017
- Africa Antiulcerant Drugs Market, Historic and Forecast, by Segment, 2013-2022
15 Antiulcerant Drugs Market Competitive Landscape
- Company Profiles
- Allergan Plc.
- Astrazeneca Plc
- Daewoong Pharmaceutical Co., Ltd.
- Eisai Co., Ltd.
- Takeda Pharmaceutical Company Limited
16 Key Mergers and Acquisitions in the Antiulcerant drugs Market
- Valeant Acquired Salix Pharmaceuticals
- Shire Acquired Meritage Pharma
- Zydus Acquired Albert David
- Allergan Acquired AstraZeneca's IBD Drug
17 Appendix
- NAICS Definitions of Industry Covered in This Report
- Antiulcerant drugs Market
- Research Methodology
List of Tables
Summary Table: Global Antiulcerant Drugs Forecast Market, Through 2022
Table 1: Global Antiulcerant Drugs Historic Market, Through 2017
Table 2: Global Antiulcerant Drugs Forecast Market, Through 2022
Table 3: Global Per Capita Average Antiulcerant Drugs Market Expenditure, 2013-2022
Table 4: Per Capita Average Antiulcerant Drugs Market Expenditure, by Country, 2017
Table 5: Global Antiulcerant Drugs Market Value, Market Size as A Percentage of Global GDP, 2013-2022
Table 6: Global Antiulcerant Drugs Market Size, Percentage Of GDP, by Country
Table 7: Global Antiulcerant Drugs Market, by Segment, 2017
Table 8: Global Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, Through 2022
Table 9: Global Antiulcerant Drugs Market, by Region, 2017
Table 10: Global Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Region, 2013-2022
Table 11: Global Antiulcerant Drugs Market, by Region, 2017
Table 12: Global Antiulcerant Drugs Market Share, by Region, 2017
Table 13: Global Antiulcerant Drugs Market, by Country, 2017
Table 14: Global Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Country, 2013-2022
Table 15: Global Antiulcerant Drugs Market, by Country, 2017
Table 16: Global Antiulcerant Drugs Market, by Country, 2017
Table 17: Asia-Pacific-Antiulcerant Drugs Historic Market, Through 2017
Table 18: Asia-Pacific Antiulcerant Drugs Forecast Market, Through 2022
Table 19: Asia-Pacific Antiulcerant Drugs Market, by Segment, 2017
Table 20: Asia-Pacific Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 21: China Antiulcerant Drugs Historic Market, Through 2017
Table 22: China Antiulcerant Drugs Forecast Market, Through 2022
Table 23: China Antiulcerant Drugs Market, by Segment, 2017
Table 24: China Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 25: India Antiulcerant Drugs Historic Market, Through 2017
Table 26: India Antiulcerant Drugs Forecast Market, Through 2022
Table 27: India Antiulcerant Drugs Market, by Segment, 2017
Table 28: India Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 29: Japan Antiulcerant Drugs Historic Market, Through 2017
Table 30: Japan Antiulcerant Drugs Forecast Market, Through 2022
Table 31: Japan Antiulcerant Drugs Market, by Segment, 2017
Table 32: Japan Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 33: Australia Antiulcerant Drugs Historic Market, Through 2017
Table 34: Australia Antiulcerant Drugs Forecast Market, Through 2022
Table 35: Australia Antiulcerant Drugs Market, by Segment, 2017
Table 36: Australia Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 37: Western Europe Antiulcerant Drugs Historic Market, Through 2017
Table 38: Western Europe Antiulcerant Drugs Forecast Market, Through 2022
Table 39: Western Europe Antiulcerant Drugs Market, by Segment, 2017
Table 40: Western Europe Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 41: UK Antiulcerant Drugs Historic Market, Through 2017
Table 42: UK Antiulcerant Drugs Forecast Market, Through 2022
Table 43: UK Antiulcerant Drugs Market, by Segment, 2017
Table 44: UK Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 45: Germany Antiulcerant Drugs Historic Market, Through 2017
Table 46: Germany Antiulcerant Drugs Forecast Market, Through 2022,
Table 47: Germany Antiulcerant Drugs Market, by Segment, 2017
Table 48: Germany Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 49: France Antiulcerant Drugs Historic Market, Through 2017
Table 50: France Antiulcerant Drugs Forecast Market, Through 2022
Table 51: France Antiulcerant Drugs Market, by Segment, 2017
Table 52: France Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 53: Italy Antiulcerant Drugs Historic Market, Through 2017
Table 54: Italy Antiulcerant Drugs Forecast Market, Through 2022
Table 55: Italy Antiulcerant Drugs Market, by Segment, 2017
Table 56: Italy Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 57: Spain Antiulcerant Drugs Historic Market, Through 2017
Table 58: Spain Antiulcerant Drugs Forecast Market, 2017-2022
Table 59: Spain Antiulcerant Drugs Market, by Segment, 2017
Table 60: Spain Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 61: Eastern Europe Antiulcerant Drugs Historic Market, Through 2017
Table 62: Eastern Europe Antiulcerant Drugs Forecast Market, Through 2022
Table 63: Eastern Europe Antiulcerant Drugs Market, by Segment, 2017
Table 64: Eastern Europe Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 65: Russia Antiulcerant Drugs Historic Market, Through 2017
Table 66: Russia Antiulcerant Drugs Forecast Market, Through 2022
Table 67: Russia Antiulcerant Drugs Market, by Segment, 2017
Table 68: Russia Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 69: North America Antiulcerant Drugs Historic Market, Through 2017
Table 70: North America Antiulcerant Drugs Forecast Market, Through 2022
Table 71: North America Antiulcerant Drugs Market, by Segment, 2017
Table 72: North America Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 73: USA Antiulcerant Drugs Historic Market, Through 2017
Table 74: USA Antiulcerant Drugs Forecast Market, Through 2022
Table 75: USA Antiulcerant Drugs Market, by Segment, 2017
Table 76: USA Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, Through 2022
Table 77: South America Antiulcerant Drugs Historic Market, Through 2017
Table 78: South America Antiulcerant Drugs Forecast Market, Through 2022
Table 79: South America Antiulcerant Drugs Market, by Segment, 2017
Table 80: South America Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, Through 2022
Table 81: Brazil Antiulcerant Drugs Historic Market, Through 2017
Table 82: Brazil Antiulcerant Drugs Forecast Market, Through 2022
Table 83: Brazil Antiulcerant Drugs Market, by Segment, 2017
Table 84: Brazil Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 85: Middle East Antiulcerant Drugs Historic Market, Through 2017
Table 86: Middle East Antiulcerant Drugs Forecast Market, Through 2022
Table 87: Middle East Antiulcerant Drugs Market, by Segment, 2017
Table 88: Middle East Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 89: Africa Antiulcerant Drugs Historic Market, 2013-2017
Table 90: Africa Antiulcerant Drugs Forecast Market, Through 2022
Table 91: Africa Antiulcerant Drugs Market, by Segment, 2017
Table 92: Africa Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 93: Global Market Share for Key Competitors of Antiulcerant Drugs Market, 2017
Table 94: Allergan plc: Financial Performance, 2013-2017
Table 95: AstraZeneca PLC: Financial Performance, 2013-2017
Table 96: Daewoong Pharmaceutical Co., Ltd.: Financial Performance, 2013-2017
Table 97: Eisai Co., Ltd.: Financial Performance, 2013-2016
Table 98: Takeda Pharmaceutical Company Limited: Financial Performance, 2013-2016
Table 99: Market Data Sources
Table 1: Global Antiulcerant Drugs Historic Market, Through 2017
Table 2: Global Antiulcerant Drugs Forecast Market, Through 2022
Table 3: Global Per Capita Average Antiulcerant Drugs Market Expenditure, 2013-2022
Table 4: Per Capita Average Antiulcerant Drugs Market Expenditure, by Country, 2017
Table 5: Global Antiulcerant Drugs Market Value, Market Size as A Percentage of Global GDP, 2013-2022
Table 6: Global Antiulcerant Drugs Market Size, Percentage Of GDP, by Country
Table 7: Global Antiulcerant Drugs Market, by Segment, 2017
Table 8: Global Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, Through 2022
Table 9: Global Antiulcerant Drugs Market, by Region, 2017
Table 10: Global Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Region, 2013-2022
Table 11: Global Antiulcerant Drugs Market, by Region, 2017
Table 12: Global Antiulcerant Drugs Market Share, by Region, 2017
Table 13: Global Antiulcerant Drugs Market, by Country, 2017
Table 14: Global Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Country, 2013-2022
Table 15: Global Antiulcerant Drugs Market, by Country, 2017
Table 16: Global Antiulcerant Drugs Market, by Country, 2017
Table 17: Asia-Pacific-Antiulcerant Drugs Historic Market, Through 2017
Table 18: Asia-Pacific Antiulcerant Drugs Forecast Market, Through 2022
Table 19: Asia-Pacific Antiulcerant Drugs Market, by Segment, 2017
Table 20: Asia-Pacific Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 21: China Antiulcerant Drugs Historic Market, Through 2017
Table 22: China Antiulcerant Drugs Forecast Market, Through 2022
Table 23: China Antiulcerant Drugs Market, by Segment, 2017
Table 24: China Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 25: India Antiulcerant Drugs Historic Market, Through 2017
Table 26: India Antiulcerant Drugs Forecast Market, Through 2022
Table 27: India Antiulcerant Drugs Market, by Segment, 2017
Table 28: India Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 29: Japan Antiulcerant Drugs Historic Market, Through 2017
Table 30: Japan Antiulcerant Drugs Forecast Market, Through 2022
Table 31: Japan Antiulcerant Drugs Market, by Segment, 2017
Table 32: Japan Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 33: Australia Antiulcerant Drugs Historic Market, Through 2017
Table 34: Australia Antiulcerant Drugs Forecast Market, Through 2022
Table 35: Australia Antiulcerant Drugs Market, by Segment, 2017
Table 36: Australia Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 37: Western Europe Antiulcerant Drugs Historic Market, Through 2017
Table 38: Western Europe Antiulcerant Drugs Forecast Market, Through 2022
Table 39: Western Europe Antiulcerant Drugs Market, by Segment, 2017
Table 40: Western Europe Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 41: UK Antiulcerant Drugs Historic Market, Through 2017
Table 42: UK Antiulcerant Drugs Forecast Market, Through 2022
Table 43: UK Antiulcerant Drugs Market, by Segment, 2017
Table 44: UK Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 45: Germany Antiulcerant Drugs Historic Market, Through 2017
Table 46: Germany Antiulcerant Drugs Forecast Market, Through 2022,
Table 47: Germany Antiulcerant Drugs Market, by Segment, 2017
Table 48: Germany Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 49: France Antiulcerant Drugs Historic Market, Through 2017
Table 50: France Antiulcerant Drugs Forecast Market, Through 2022
Table 51: France Antiulcerant Drugs Market, by Segment, 2017
Table 52: France Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 53: Italy Antiulcerant Drugs Historic Market, Through 2017
Table 54: Italy Antiulcerant Drugs Forecast Market, Through 2022
Table 55: Italy Antiulcerant Drugs Market, by Segment, 2017
Table 56: Italy Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 57: Spain Antiulcerant Drugs Historic Market, Through 2017
Table 58: Spain Antiulcerant Drugs Forecast Market, 2017-2022
Table 59: Spain Antiulcerant Drugs Market, by Segment, 2017
Table 60: Spain Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 61: Eastern Europe Antiulcerant Drugs Historic Market, Through 2017
Table 62: Eastern Europe Antiulcerant Drugs Forecast Market, Through 2022
Table 63: Eastern Europe Antiulcerant Drugs Market, by Segment, 2017
Table 64: Eastern Europe Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 65: Russia Antiulcerant Drugs Historic Market, Through 2017
Table 66: Russia Antiulcerant Drugs Forecast Market, Through 2022
Table 67: Russia Antiulcerant Drugs Market, by Segment, 2017
Table 68: Russia Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 69: North America Antiulcerant Drugs Historic Market, Through 2017
Table 70: North America Antiulcerant Drugs Forecast Market, Through 2022
Table 71: North America Antiulcerant Drugs Market, by Segment, 2017
Table 72: North America Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 73: USA Antiulcerant Drugs Historic Market, Through 2017
Table 74: USA Antiulcerant Drugs Forecast Market, Through 2022
Table 75: USA Antiulcerant Drugs Market, by Segment, 2017
Table 76: USA Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, Through 2022
Table 77: South America Antiulcerant Drugs Historic Market, Through 2017
Table 78: South America Antiulcerant Drugs Forecast Market, Through 2022
Table 79: South America Antiulcerant Drugs Market, by Segment, 2017
Table 80: South America Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, Through 2022
Table 81: Brazil Antiulcerant Drugs Historic Market, Through 2017
Table 82: Brazil Antiulcerant Drugs Forecast Market, Through 2022
Table 83: Brazil Antiulcerant Drugs Market, by Segment, 2017
Table 84: Brazil Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 85: Middle East Antiulcerant Drugs Historic Market, Through 2017
Table 86: Middle East Antiulcerant Drugs Forecast Market, Through 2022
Table 87: Middle East Antiulcerant Drugs Market, by Segment, 2017
Table 88: Middle East Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 89: Africa Antiulcerant Drugs Historic Market, 2013-2017
Table 90: Africa Antiulcerant Drugs Forecast Market, Through 2022
Table 91: Africa Antiulcerant Drugs Market, by Segment, 2017
Table 92: Africa Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 93: Global Market Share for Key Competitors of Antiulcerant Drugs Market, 2017
Table 94: Allergan plc: Financial Performance, 2013-2017
Table 95: AstraZeneca PLC: Financial Performance, 2013-2017
Table 96: Daewoong Pharmaceutical Co., Ltd.: Financial Performance, 2013-2017
Table 97: Eisai Co., Ltd.: Financial Performance, 2013-2016
Table 98: Takeda Pharmaceutical Company Limited: Financial Performance, 2013-2016
Table 99: Market Data Sources
List of Figures
Summary Figure: Global Antiulcerant Drugs Forecast Market, 2017-2022
Figure 1: Global Antiulcerant Drugs Historic Market, 2013-2017
Figure 2: Global Antiulcerant Drugs Forecast Market, 2017-2022
Figure 3: PESTEL Analysis: Global Antiulcerant Drugs Market, 2017
Figure 4: Global Per Capita Average Antiulcerant Drugs Market Expenditure, 2013-2022
Figure 5: Per Capita Average Antiulcerant Drugs Market Expenditure, by Country, 2017
Figure 6: Global Antiulcerant Drugs Market Value, Market Size as A Percentage of Global GDP, 2013-2022
Figure 7: Global Antiulcerant Drugs Market Size, Percentage Of GDP, by Country
Figure 8: Global Antiulcerant Drugs Market Share, by Segment, 2017
Figure 9: Global Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 10: Global Antiulcerant Drugs Market Share, by Region, 2017
Figure 11: Global Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Region, 2013-2022
Figure 12: Global Antiulcerant Drugs Market, by Region, 2017
Figure 13: Global Antiulcerant Drugs Market, by Country, 2017
Figure 14: Global Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Country, 2013-2022
Figure 15: Global Antiulcerant Drugs Market Share, by Country, 2017
Figure 16: Asia-Pacific Antiulcerant Drugs Historic Market, 2013-2017
Figure 17: Asia-Pacific Antiulcerant Drugs Forecast Market, 2017-2022
Figure 18: Asia-Pacific Antiulcerant Drugs Market Share, by Segment, 2017
Figure 19: Asia-Pacific Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 20: China Antiulcerant Drugs Historic Market, 2013-2017
Figure 21: China Antiulcerant Drugs Forecast Market, 2017-2022
Figure 22: China Antiulcerant Drugs Market Share, by Segment, 2017
Figure 23: China Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 24: India Antiulcerant Drugs Historic Market, 2013-2017
Figure 25: India Antiulcerant Drugs Forecast Market, 2017-2022
Figure 26: India Antiulcerant Drugs Market Share, by Segment, 2017
Figure 27: India Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 28: Japan Antiulcerant Drugs Historic Market, 2013-2017
Figure 29: Japan Antiulcerant Drugs Forecast Market, 2017-2022
Figure 30: Japan Antiulcerant Drugs Market Share, by Segment, 2017
Figure 31: Japan Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 32: Australia Antiulcerant Drugs Historic Market, 2013-2017
Figure 33: Australia Antiulcerant Drugs Forecast Market, 2017-2022
Figure 34: Australia Antiulcerant Drugs Market Share, by Segment, 2017
Figure 35: Australia Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 36: Western Europe Antiulcerant Drugs Historic Market, 2013-2017
Figure 37: Western Europe Antiulcerant Drugs Forecast Market, 2017-2022
Figure 38: Western Europe Antiulcerant Drugs Market Share, by Segment, 2017
Figure 39: Western Europe Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 40: UK Antiulcerant Drugs Historic Market, 2013-2017
Figure 41: UK Antiulcerant Drugs Forecast Market, 2017-2022
Figure 42: UK Antiulcerant Drugs Market Share, by Segment, 2017
Figure 43: UK Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 44: Germany Antiulcerant Drugs Historic Market, 2013-2017
Figure 45: Germany Antiulcerant Drugs Forecast Market, 2017-2022
Figure 46: Germany Antiulcerant Drugs Market Share, by Segment, 2017
Figure 47: Germany Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 48: France Antiulcerant Drugs Historic Market, 2013-2017
Figure 49: France Antiulcerant Drugs Forecast Market, 2017-2022
Figure 50: France Antiulcerant Drugs Market Share, by Segment, 2017
Figure 51: France Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 52: Italy Antiulcerant Drugs Historic Market, 2013-2017
Figure 53: Italy Antiulcerant Drugs Forecast Market, 2017-2022
Figure 54: Italy Antiulcerant Drugs Market Share, by Segment, 2017
Figure 55: Italy Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 56: Spain Antiulcerant Drugs Historic Market, 2013-2017
Figure 57: Spain Antiulcerant Drugs Forecast Market, 2017-2022
Figure 58: Spain Antiulcerant Drugs Market Share, by Segment, 2017
Figure 59: Spain Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 60: Eastern Europe Antiulcerant Drugs Historic Market, 2013-2017
Figure 61: Eastern Europe Antiulcerant Drugs Forecast Market, 2017-2022
Figure 62: Eastern Europe Antiulcerant Drugs Market Share, by Segment, 2017
Figure 63: Eastern Europe Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 64: Russia Antiulcerant Drugs Historic Market, 2013-2017
Figure 65: Russia Antiulcerant Drugs Forecast Market, 2017-2022
Figure 66: Russia Antiulcerant Drugs Market, by Segment, 2017
Figure 67: Russia Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 68: North America Antiulcerant Drugs Historic Market, 2013-2017
Figure 69: North America Antiulcerant Drugs Forecast Market, 2017-2022
Figure 70: North America Antiulcerant Drugs Market Share, by Segment, 2017
Figure 71: North America Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 72: USA Antiulcerant Drugs Historic Market, 2013-2017
Figure 73: USA Antiulcerant Drugs Forecast Market, 2017-2022
Figure 74: USA Antiulcerant Drugs Market Share, by Segment, 2017
Figure 75: USA Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 76: South America Antiulcerant Drugs Historic Market, 2013-2017
Figure 77: South America Antiulcerant Drugs Forecast Market, 2017-2022
Figure 78: South America Antiulcerant Drugs Market Share, by Segment, 2017
Figure 79: South America Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 80: Brazil Antiulcerant Drugs Historic Market, 2013-2017
Figure 81: Brazil Antiulcerant Drugs Forecast Market, 2017-2022
Figure 82: Brazil Antiulcerant Drugs Market Share, by Segment, 2017
Figure 83: Brazil Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 84: Middle East Antiulcerant Drugs Historic Market, 2013-2017
Figure 85: Middle East Antiulcerant Drugs Forecast Market, 2017-2022
Figure 86: Middle East Antiulcerant Drugs Market Share, by Segment, 2017
Figure 87: Middle East Antiulcerant Drugs Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 88: Africa Antiulcerant Drugs Historic Market, 2013-2017
Figure 89: Africa Antiulcerant Drugs Forecast Market, 2017-2022
Figure 90: Africa Antiulcerant Drugs Market Share, by Segment, 2017
Figure 91: Africa Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 92: Global Market Share for Key Competitors of Antiulcerant Drugs Market, 2017
Figure 93: Allergan plc: Financial Performance, 2013-2017
Figure 94: AstraZeneca PLC: Financial Performance, 2013-2017
Figure 95: Daewoong Pharmaceutical Co., Ltd.: Financial Performance, 2013-2017
Figure 96: Eisai Co., Ltd.: Financial Performance, 2013-2016
Figure 97: Takeda Pharmaceutical Company Limited: Financial Performance, 2013-2016
Figure 1: Global Antiulcerant Drugs Historic Market, 2013-2017
Figure 2: Global Antiulcerant Drugs Forecast Market, 2017-2022
Figure 3: PESTEL Analysis: Global Antiulcerant Drugs Market, 2017
Figure 4: Global Per Capita Average Antiulcerant Drugs Market Expenditure, 2013-2022
Figure 5: Per Capita Average Antiulcerant Drugs Market Expenditure, by Country, 2017
Figure 6: Global Antiulcerant Drugs Market Value, Market Size as A Percentage of Global GDP, 2013-2022
Figure 7: Global Antiulcerant Drugs Market Size, Percentage Of GDP, by Country
Figure 8: Global Antiulcerant Drugs Market Share, by Segment, 2017
Figure 9: Global Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 10: Global Antiulcerant Drugs Market Share, by Region, 2017
Figure 11: Global Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Region, 2013-2022
Figure 12: Global Antiulcerant Drugs Market, by Region, 2017
Figure 13: Global Antiulcerant Drugs Market, by Country, 2017
Figure 14: Global Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Country, 2013-2022
Figure 15: Global Antiulcerant Drugs Market Share, by Country, 2017
Figure 16: Asia-Pacific Antiulcerant Drugs Historic Market, 2013-2017
Figure 17: Asia-Pacific Antiulcerant Drugs Forecast Market, 2017-2022
Figure 18: Asia-Pacific Antiulcerant Drugs Market Share, by Segment, 2017
Figure 19: Asia-Pacific Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 20: China Antiulcerant Drugs Historic Market, 2013-2017
Figure 21: China Antiulcerant Drugs Forecast Market, 2017-2022
Figure 22: China Antiulcerant Drugs Market Share, by Segment, 2017
Figure 23: China Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 24: India Antiulcerant Drugs Historic Market, 2013-2017
Figure 25: India Antiulcerant Drugs Forecast Market, 2017-2022
Figure 26: India Antiulcerant Drugs Market Share, by Segment, 2017
Figure 27: India Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 28: Japan Antiulcerant Drugs Historic Market, 2013-2017
Figure 29: Japan Antiulcerant Drugs Forecast Market, 2017-2022
Figure 30: Japan Antiulcerant Drugs Market Share, by Segment, 2017
Figure 31: Japan Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 32: Australia Antiulcerant Drugs Historic Market, 2013-2017
Figure 33: Australia Antiulcerant Drugs Forecast Market, 2017-2022
Figure 34: Australia Antiulcerant Drugs Market Share, by Segment, 2017
Figure 35: Australia Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 36: Western Europe Antiulcerant Drugs Historic Market, 2013-2017
Figure 37: Western Europe Antiulcerant Drugs Forecast Market, 2017-2022
Figure 38: Western Europe Antiulcerant Drugs Market Share, by Segment, 2017
Figure 39: Western Europe Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 40: UK Antiulcerant Drugs Historic Market, 2013-2017
Figure 41: UK Antiulcerant Drugs Forecast Market, 2017-2022
Figure 42: UK Antiulcerant Drugs Market Share, by Segment, 2017
Figure 43: UK Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 44: Germany Antiulcerant Drugs Historic Market, 2013-2017
Figure 45: Germany Antiulcerant Drugs Forecast Market, 2017-2022
Figure 46: Germany Antiulcerant Drugs Market Share, by Segment, 2017
Figure 47: Germany Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 48: France Antiulcerant Drugs Historic Market, 2013-2017
Figure 49: France Antiulcerant Drugs Forecast Market, 2017-2022
Figure 50: France Antiulcerant Drugs Market Share, by Segment, 2017
Figure 51: France Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 52: Italy Antiulcerant Drugs Historic Market, 2013-2017
Figure 53: Italy Antiulcerant Drugs Forecast Market, 2017-2022
Figure 54: Italy Antiulcerant Drugs Market Share, by Segment, 2017
Figure 55: Italy Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 56: Spain Antiulcerant Drugs Historic Market, 2013-2017
Figure 57: Spain Antiulcerant Drugs Forecast Market, 2017-2022
Figure 58: Spain Antiulcerant Drugs Market Share, by Segment, 2017
Figure 59: Spain Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 60: Eastern Europe Antiulcerant Drugs Historic Market, 2013-2017
Figure 61: Eastern Europe Antiulcerant Drugs Forecast Market, 2017-2022
Figure 62: Eastern Europe Antiulcerant Drugs Market Share, by Segment, 2017
Figure 63: Eastern Europe Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 64: Russia Antiulcerant Drugs Historic Market, 2013-2017
Figure 65: Russia Antiulcerant Drugs Forecast Market, 2017-2022
Figure 66: Russia Antiulcerant Drugs Market, by Segment, 2017
Figure 67: Russia Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 68: North America Antiulcerant Drugs Historic Market, 2013-2017
Figure 69: North America Antiulcerant Drugs Forecast Market, 2017-2022
Figure 70: North America Antiulcerant Drugs Market Share, by Segment, 2017
Figure 71: North America Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 72: USA Antiulcerant Drugs Historic Market, 2013-2017
Figure 73: USA Antiulcerant Drugs Forecast Market, 2017-2022
Figure 74: USA Antiulcerant Drugs Market Share, by Segment, 2017
Figure 75: USA Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 76: South America Antiulcerant Drugs Historic Market, 2013-2017
Figure 77: South America Antiulcerant Drugs Forecast Market, 2017-2022
Figure 78: South America Antiulcerant Drugs Market Share, by Segment, 2017
Figure 79: South America Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 80: Brazil Antiulcerant Drugs Historic Market, 2013-2017
Figure 81: Brazil Antiulcerant Drugs Forecast Market, 2017-2022
Figure 82: Brazil Antiulcerant Drugs Market Share, by Segment, 2017
Figure 83: Brazil Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 84: Middle East Antiulcerant Drugs Historic Market, 2013-2017
Figure 85: Middle East Antiulcerant Drugs Forecast Market, 2017-2022
Figure 86: Middle East Antiulcerant Drugs Market Share, by Segment, 2017
Figure 87: Middle East Antiulcerant Drugs Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 88: Africa Antiulcerant Drugs Historic Market, 2013-2017
Figure 89: Africa Antiulcerant Drugs Forecast Market, 2017-2022
Figure 90: Africa Antiulcerant Drugs Market Share, by Segment, 2017
Figure 91: Africa Antiulcerant Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 92: Global Market Share for Key Competitors of Antiulcerant Drugs Market, 2017
Figure 93: Allergan plc: Financial Performance, 2013-2017
Figure 94: AstraZeneca PLC: Financial Performance, 2013-2017
Figure 95: Daewoong Pharmaceutical Co., Ltd.: Financial Performance, 2013-2017
Figure 96: Eisai Co., Ltd.: Financial Performance, 2013-2016
Figure 97: Takeda Pharmaceutical Company Limited: Financial Performance, 2013-2016
Executive Summary
The global antiulcerant drugs market growth outlook is positive with significant growth potential for antiulcerant drugs market in emerging countries. Rising disposable income in developed countries, growing awareness of the disease, busy lifestyles, technological advances such as big data, 3D printing and IoT is aiding the antiulcerant drugs market growth.
The market for antiulcerant drugs is fragmented with a large number of players. Major players in the market are AstraZeneca PLC, Allergan plc, Daewoong Pharmaceutical Co., Ltd., Eisai Co., Ltd ,Takeda Pharmaceutical Company others. Proton Pump Inhibitors accounted for the largest share of the market for antiulcerant drugs market in 2017. The highest growth is projected to come from H2 Receptor Antagonists segment. Major factors included an aging population, sedentary lifestyles and increasing awareness on ulcer disease.
North America is the largest market for antiulcerant drugs market. It was followed by Asia Pacific and Western Europe. Going forward, Africa is expected to witness the fastest growth in the antiulcerant drugs market, followed by North America.
The USA is the largest market in terms of value and in the antiulcerant drugs market. India and China are forecasted to have the fastest growth. The market is challenged by restraints such as unfavorable laws for drug patents and rising trade protectionism.
Companies Mentioned
- Allergan Plc.
- Astrazeneca Plc
- Daewoong Pharmaceutical Co., Ltd.
- Eisai Co., Ltd.
- Takeda Pharmaceutical Company Limited
